Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ELF4 |
| Upstream (Parents) |
|---|
| (<<) HLF → ELF4 |
| (<<) ZIC1 → ELF4 |
| (<<) NR1H4 → ELF4 |
| (<<) HHEX → ELF4 |
| (<<) MEIS2 → ELF4 |
| (<<) GTF2IRD1 → ELF4 |
| Downstream (Children) |
|---|
| ELF4 → SATB2 (>>) |
| ELF4 → CDX2 (>>) |
| ELF4 → NFE2 (>>) |
| ELF4 → EHF (>>) |
| ELF4 → ZNF215 (>>) |
| ELF4 → LEF1 (>>) |
| ELF4 → HOXB7 (>>) |
| ELF4 → NFE2L3 (>>) |
| ELF4 → VDR (>>) |
| ELF4 → PTTG1 (>>) |
| ELF4 → KLF4 (>>) |
| ELF4 → ARID3A (>>) |
| ELF4 → STAT2 (>>) |
| ELF4 → TCF7 (>>) |
| ELF4 → BCL11B (>>) |
| ELF4 → SREBF1 (>>) |
| ELF4 → MEIS3P1 (>>) |
